[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $nktrs $NKTR sees a surge in social engagement amid discussions of potential damages from LLY and positive trial results. Users are anticipating a favorable outcome for NKTR's legal claims and drug development, with SNY's market cap dropping significantly. ### About $nktrs Social media analysis of the stock ticker $nktrs. ### Engagements: XX [#](/topic/$nktrs/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$nktrs/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXXXX **1 Week**: XXXXX -XX% **1 Month**: XXXXXX -XX% **1-Year High**: XXXXXX on 2025-10-06 **1-Year Low**: XX on 2025-07-10 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$nktrs/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$nktrs/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1-Year High**: X on 2025-09-10 **1-Year Low**: X on 2025-06-27 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$nktrs/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$nktrs/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $nktrs in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1-Year High**: X on 2025-09-10 **1-Year Low**: X on 2025-06-27 The most influential creators that mention $nktrs in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@A_May_MD](/creator/twitter/A_May_MD) | X | XXXXXX | X | XX | [View More](/list/creators/$nktrs/100) **Top assets mentioned** In the posts about $nktrs in the last XX hours [Sanofi (SNY)](/topic/sanofi) [Synthetify (SNY)](/topic/$sny) **Top topics mentioned** In the posts about $nktrs in the last XX hours [sanofi](/topic/sanofi), [stocks healthcare](/topic/stocks-healthcare), [$sny](/topic/$sny), [$nktr](/topic/$nktr), [$122b](/topic/$122b), [$snys](/topic/$snys) ### Top Social Posts [#](/topic/$nktrs/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "And one more thing - I do hear the argument "well $SNY traded down because P3 efficacy got worse compared to P2. Couldn't the same thing happen to $NKTR" Sure it could but $SNY's efficacy decayed almost entirely due to higher placebo response rates in P3 compared to P2 jumping from XX% to 19%. $NKTR's P2b pbo rate was already XX% - just X points off of where $SNY's P3 ended up. $NKTR is in a *fantastic* spot to be able to reproduce a P3 EASI75 delta in the same range as their P2's was. If that happens this will be a biotech "phoenix from the ashes" story of the ages Last time I'll say it. I" [X Link](https://x.com/A_May_MD/status/1963715974495928523) [@A_May_MD](/creator/x/A_May_MD) 2025-09-04T21:29Z 17.5K followers, 40.1K engagements "Final Numbers: $SNY down $12.2B $NKTR up $0.11B. $SNY lost 111x what $NKTR gained today. I'm a broken (and biased) record on $NKTR's valuation but seriously - why isn't this thing getting *any* respect for the size of the 2L+ atopic derm market and the P2b data they already have I feel like I'm going insane when I review all the data and market sizes here and ending up with this $700M valuation. It's similar to how I felt when I posted what I considered to be borderline mathematical proof that $ABVX was going to hit in P3 only for the stock to trade down a few cents over the next XX hours" [X Link](https://x.com/A_May_MD/status/1963715972331651194) [@A_May_MD](/creator/x/A_May_MD) 2025-09-04T21:29Z 17.5K followers, 75.7K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$NKTR sees a surge in social engagement amid discussions of potential damages from LLY and positive trial results. Users are anticipating a favorable outcome for NKTR's legal claims and drug development, with SNY's market cap dropping significantly.
Social media analysis of the stock ticker $nktrs.
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
1-Year High: XXXXXX on 2025-10-06
1-Year Low: XX on 2025-07-10
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-09-10
1-Year Low: X on 2025-06-27
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $nktrs in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-09-10
1-Year Low: X on 2025-06-27
The most influential creators that mention $nktrs in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@A_May_MD | X | XXXXXX | X | XX |
Top assets mentioned In the posts about $nktrs in the last XX hours
Top topics mentioned In the posts about $nktrs in the last XX hours
sanofi, stocks healthcare, $sny, $nktr, $122b, $snys
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"And one more thing - I do hear the argument "well $SNY traded down because P3 efficacy got worse compared to P2. Couldn't the same thing happen to $NKTR" Sure it could but $SNY's efficacy decayed almost entirely due to higher placebo response rates in P3 compared to P2 jumping from XX% to 19%. $NKTR's P2b pbo rate was already XX% - just X points off of where $SNY's P3 ended up. $NKTR is in a fantastic spot to be able to reproduce a P3 EASI75 delta in the same range as their P2's was. If that happens this will be a biotech "phoenix from the ashes" story of the ages Last time I'll say it. I"
X Link @A_May_MD 2025-09-04T21:29Z 17.5K followers, 40.1K engagements
"Final Numbers: $SNY down $12.2B $NKTR up $0.11B. $SNY lost 111x what $NKTR gained today. I'm a broken (and biased) record on $NKTR's valuation but seriously - why isn't this thing getting any respect for the size of the 2L+ atopic derm market and the P2b data they already have I feel like I'm going insane when I review all the data and market sizes here and ending up with this $700M valuation. It's similar to how I felt when I posted what I considered to be borderline mathematical proof that $ABVX was going to hit in P3 only for the stock to trade down a few cents over the next XX hours"
X Link @A_May_MD 2025-09-04T21:29Z 17.5K followers, 75.7K engagements
/topic/$nktrs